These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25421437)

  • 1. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders.
    Peyrovian B; Rosenblat JD; Pan Z; Iacobucci M; Brietzke E; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():387-404. PubMed ID: 30738126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the overlap between subjective and objective cognitive impairments in MDD?
    Fava M; Mahableshwarkar AR; Jacobson W; Zhong W; Keefe RS; Olsen CK; Jaeger J
    Ann Clin Psychiatry; 2018 Aug; 30(3):176-184. PubMed ID: 30028891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and managing Cognition in the Depressed Patient.
    Papakostas GI; Culpepper L
    J Clin Psychiatry; 2015 Apr; 76(4):418-25. PubMed ID: 25919832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder.
    Belgaied W; Samp J; Vimont A; Rémuzat C; Aballéa S; El Hammi E; Kooli A; Toumi M; Akhras K
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):133-41. PubMed ID: 24314852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian psychiatrists' perception on cognitive symptoms in major depressive disorder.
    Albert U; Brugnoli R; Caraci F; Dell'Osso B; Di Sciascio G; Tortorella A; Vampini C; Cataldo N; Pegoraro V
    Int J Psychiatry Clin Pract; 2016; 20(1):2-9. PubMed ID: 26523906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management.
    Culpepper L; Lam RW; McIntyre RS
    J Clin Psychiatry; 2017; 78(9):1383-1394. PubMed ID: 29345866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction in unipolar depression: implications for treatment.
    Trivedi MH; Greer TL
    J Affect Disord; 2014 Jan; 152-154():19-27. PubMed ID: 24215896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder.
    Bakkour N; Samp J; Akhras K; El Hammi E; Soussi I; Zahra F; Duru G; Kooli A; Toumi M
    Psychiatry Res; 2014 May; 216(3):291-302. PubMed ID: 24656516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Procognitive Effects of Modafinil in Major Depressive Disorder: A Systematic Review.
    Vaccarino SR; McInerney SJ; Kennedy SH; Bhat V
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31599501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
    McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
    CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using measurement strategies to identify and monitor residual symptoms.
    McIntyre RS
    J Clin Psychiatry; 2013; 74 Suppl 2():14-8. PubMed ID: 24191973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.
    Godard J; Grondin S; Baruch P; Lafleur MF
    Psychiatry Res; 2011 Dec; 190(2-3):244-52. PubMed ID: 21764461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
    Blumberg MJ; Vaccarino SR; McInerney SJ
    J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.